Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Dec;76(Suppl 5):v45–v52. doi: 10.1136/jnnp.2005.082149

Use of laboratory and imaging investigations in dementia

W M van der Flier, P Scheltens
PMCID: PMC1765713  PMID: 16291921

Full Text

The Full Text of this article is available as a PDF (501.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blennow Kaj, Hampel Harald. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003 Oct;2(10):605–613. doi: 10.1016/s1474-4422(03)00530-1. [DOI] [PubMed] [Google Scholar]
  2. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239–259. doi: 10.1007/BF00308809. [DOI] [PubMed] [Google Scholar]
  3. Claus J. J., Kwa V. I., Teunisse S., Walstra G. J., van Gool W. A., Koelman J. H., Bour L. J., Ongerboer de Visser B. W. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer disease. Alzheimer Dis Assoc Disord. 1998 Sep;12(3):167–174. doi: 10.1097/00002093-199809000-00008. [DOI] [PubMed] [Google Scholar]
  4. Fox N. C., Warrington E. K., Freeborough P. A., Hartikainen P., Kennedy A. M., Stevens J. M., Rossor M. N. Presymptomatic hippocampal atrophy in Alzheimer's disease. A longitudinal MRI study. Brain. 1996 Dec;119(Pt 6):2001–2007. doi: 10.1093/brain/119.6.2001. [DOI] [PubMed] [Google Scholar]
  5. Gosche K. M., Mortimer J. A., Smith C. D., Markesbery W. R., Snowdon D. A. Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study. Neurology. 2002 May 28;58(10):1476–1482. doi: 10.1212/wnl.58.10.1476. [DOI] [PubMed] [Google Scholar]
  6. Hejl A., Høgh P., Waldemar G. Potentially reversible conditions in 1000 consecutive memory clinic patients. J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):390–394. doi: 10.1136/jnnp.73.4.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jack C. R., Jr, Petersen R. C., Xu Y. C., Waring S. C., O'Brien P. C., Tangalos E. G., Smith G. E., Ivnik R. J., Kokmen E. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology. 1997 Sep;49(3):786–794. doi: 10.1212/wnl.49.3.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jagust William. Molecular neuroimaging in Alzheimer's disease. NeuroRx. 2004 Apr;1(2):206–212. doi: 10.1602/neurorx.1.2.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jelic V., Johansson S. E., Almkvist O., Shigeta M., Julin P., Nordberg A., Winblad B., Wahlund L. O. Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging. 2000 Jul-Aug;21(4):533–540. doi: 10.1016/s0197-4580(00)00153-6. [DOI] [PubMed] [Google Scholar]
  10. Klunk William E., Engler Henry, Nordberg Agneta, Wang Yanming, Blomqvist Gunnar, Holt Daniel P., Bergström Mats, Savitcheva Irina, Huang Guo-feng, Estrada Sergio. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004 Mar;55(3):306–319. doi: 10.1002/ana.20009. [DOI] [PubMed] [Google Scholar]
  11. Knopman D. S., DeKosky S. T., Cummings J. L., Chui H., Corey-Bloom J., Relkin N., Small G. W., Miller B., Stevens J. C. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1143–1153. doi: 10.1212/wnl.56.9.1143. [DOI] [PubMed] [Google Scholar]
  12. Korf Esther S. C., Wahlund Lars-Olof, Visser Pieter Jelle, Scheltens Philip. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology. 2004 Jul 13;63(1):94–100. doi: 10.1212/01.wnl.0000133114.92694.93. [DOI] [PubMed] [Google Scholar]
  13. Mayeux R., Saunders A. M., Shea S., Mirra S., Evans D., Roses A. D., Hyman B. T., Crain B., Tang M. X., Phelps C. H. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med. 1998 Feb 19;338(8):506–511. doi: 10.1056/NEJM199802193380804. [DOI] [PubMed] [Google Scholar]
  14. Neary D., Snowden J. S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P. H., Albert M. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998 Dec;51(6):1546–1554. doi: 10.1212/wnl.51.6.1546. [DOI] [PubMed] [Google Scholar]
  15. Petersen R. C., Smith G. E., Waring S. C., Ivnik R. J., Tangalos E. G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999 Mar;56(3):303–308. doi: 10.1001/archneur.56.3.303. [DOI] [PubMed] [Google Scholar]
  16. Román G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J. M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250–260. doi: 10.1212/wnl.43.2.250. [DOI] [PubMed] [Google Scholar]
  17. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H. C., Vermersch P., Kuiper M., Steinling M., Wolters E. C., Valk J. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992 Oct;55(10):967–972. doi: 10.1136/jnnp.55.10.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Scheltens Philip, Fox Nick, Barkhof Frederik, De Carli Charles. Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol. 2002 May;1(1):13–21. doi: 10.1016/s1474-4422(02)00002-9. [DOI] [PubMed] [Google Scholar]
  19. Shoghi-Jadid Kooresh, Small Gary W., Agdeppa Eric D., Kepe Vladimir, Ercoli Linda M., Siddarth Prabha, Read Stephen, Satyamurthy Nagichettiar, Petric Andrej, Huang Sung-Cheng. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002 Jan-Feb;10(1):24–35. [PubMed] [Google Scholar]
  20. Snowdon D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A., Markesbery W. R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 1997 Mar 12;277(10):813–817. [PubMed] [Google Scholar]
  21. Strittmatter W. J., Roses A. D. Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4725–4727. doi: 10.1073/pnas.92.11.4725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Strozyk D., Blennow K., White L. R., Launer L. J. CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study. Neurology. 2003 Feb 25;60(4):652–656. doi: 10.1212/01.wnl.0000046581.81650.d0. [DOI] [PubMed] [Google Scholar]
  23. Zerr I., Pocchiari M., Collins S., Brandel J. P., de Pedro Cuesta J., Knight R. S., Bernheimer H., Cardone F., Delasnerie-Lauprêtre N., Cuadrado Corrales N. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000 Sep 26;55(6):811–815. doi: 10.1212/wnl.55.6.811. [DOI] [PubMed] [Google Scholar]
  24. van Straaten Elisabeth C. W., Scheltens Philip, Knol Dirk L., van Buchem Mark A., van Dijk Ewout J., Hofman Paul A. M., Karas Giorgos, Kjartansson Olafur, de Leeuw Frank-Erik, Prins Niels D. Operational definitions for the NINDS-AIREN criteria for vascular dementia: an interobserver study. Stroke. 2003 Jul 10;34(8):1907–1912. doi: 10.1161/01.STR.0000083050.44441.10. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES